See more : Omega Therapeutics, Inc. (OMGA) Income Statement Analysis – Financial Results
Complete financial analysis of IMAC Holdings, Inc. (IMAC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of IMAC Holdings, Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
You may be interested
- The PNC Financial Services Group, Inc. (PNC) Income Statement Analysis – Financial Results
- HealthStream, Inc. (HSTM) Income Statement Analysis – Financial Results
- Ankit Metal & Power Limited (ANKITMETAL.BO) Income Statement Analysis – Financial Results
- Shanghai Kaichuang Marine International Co., Ltd. (600097.SS) Income Statement Analysis – Financial Results
- Hidili Industry International Development Limited (HIIDQ) Income Statement Analysis – Financial Results
IMAC Holdings, Inc. (IMAC)
About IMAC Holdings, Inc.
IMAC Holdings, Inc. owns, manages, and subleases a chain of innovative medical advancements and care regeneration centers in the United States. The company's outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, ligament and tendon damage, and other related soft tissue conditions, as well as back, knee, and joint pains. It also provides physical therapy and spinal decompression, and chiropractic manipulation. The company owns or manages 15 outpatient medical clinics in Kentucky, Missouri, Tennessee, Illinois, Louisiana, and Florida. IMAC Holdings, Inc. was founded in 2000 and is headquartered in Brentwood, Tennessee.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 5.20M | 16.19M | 14.39M | 12.84M | 15.13M | 6.70M | 786.03K | 15.00K |
| Cost of Revenue | 1.35M | 1.51M | 1.63M | 1.62M | 2.54M | 933.91K | 63.22K | 4.27K |
| Gross Profit | 3.85M | 14.68M | 12.76M | 11.21M | 12.59M | 5.77M | 722.81K | 10.73K |
| Gross Profit Ratio | 74.05% | 90.68% | 88.68% | 87.35% | 83.21% | 86.06% | 91.96% | 71.56% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.46M | 21.80M | 19.73M | 15.44M | 15.98M | 7.81M | 1.45M | 204.78K |
| Selling & Marketing | 7.73K | 1.10M | 1.32M | 933.34K | 1.24M | 859.19K | 119.87K | 25.00K |
| SG&A | 1.47M | 22.90M | 21.06M | 16.38M | 17.22M | 8.67M | 1.57M | 229.78K |
| Other Expenses | 3.56M | 1.63M | 1.65M | 1.31M | 1.55M | 18.36K | 65.90K | 0.00 |
| Operating Expenses | 5.03M | 24.53M | 22.71M | 17.68M | 18.77M | 9.32M | 1.64M | 229.78K |
| Cost & Expenses | 6.38M | 26.03M | 24.33M | 19.31M | 21.31M | 10.25M | 1.70M | 234.05K |
| Interest Income | 0.00 | 10.58K | 2.89K | 6.07K | 7.79K | 7.54K | 14.82K | 4.00 |
| Interest Expense | 0.00 | 14.19K | 504.10K | 563.07K | 897.69K | 153.82K | 27.15K | 4.00 |
| Depreciation & Amortization | 403.59K | 1.63M | 1.65M | 1.72M | 1.55M | 651.07K | 65.90K | 219.05K |
| EBITDA | -5.95M | -10.20M | -8.39M | -3.26M | -4.50M | -2.98M | -823.48K | -397.44K |
| EBITDA Ratio | -114.43% | -50.91% | -57.28% | -36.96% | -30.68% | -44.47% | -104.42% | -2,649.60% |
| Operating Income | -6.38M | -9.85M | -9.95M | -6.47M | -6.19M | -3.55M | -915.07K | -219.05K |
| Operating Income Ratio | -122.68% | -60.85% | -69.16% | -50.43% | -40.89% | -53.00% | -116.42% | -1,460.31% |
| Total Other Income/Expenses | -99.85K | 6.11K | -443.89K | 993.86K | -765.96K | -233.48K | -1.47K | -178.39K |
| Income Before Tax | -6.48M | -18.31M | -10.54M | -5.54M | -6.95M | -3.78M | -916.53K | -397.44K |
| Income Before Tax Ratio | -124.60% | -113.14% | -73.28% | -43.18% | -45.96% | -56.48% | -116.60% | -2,649.60% |
| Income Tax Expense | 0.00 | 8.43M | 561.43K | 24.37K | 427.20K | -79.65K | -818.59K | -16.65K |
| Net Income | -9.42M | -26.74M | -11.10M | -5.57M | -7.38M | -3.05M | -57.18K | -380.80K |
| Net Income Ratio | -181.23% | -165.24% | -77.18% | -43.37% | -48.78% | -45.57% | -7.27% | -2,538.65% |
| EPS | -5.06 | -28.38 | -14.77 | -15.11 | -28.55 | -12.65 | -0.38 | -2.56 |
| EPS Diluted | -7.36 | -28.38 | -14.77 | -15.11 | -28.55 | -12.65 | -0.38 | -2.56 |
| Weighted Avg Shares Out | 1.62M | 942.46K | 751.72K | 368.34K | 258.45K | 241.43K | 150.40K | 149.02K |
| Weighted Avg Shares Out (Dil) | 1.11M | 942.46K | 751.72K | 368.34K | 258.45K | 241.43K | 150.40K | 149.02K |
Missouri Republicans on the verge of gutting gerrymandering reform
Lawmakers are sending a new ballot proposal that would undo 2018 protections against manipulation of electoral maps
On May 10, 1970, the Bruins were ready to realize a dream. Bobby Orr made it come true - The Boston Globe
The memories of that day are etched not only in the minds of Bruins fans but also of those who participated in the game.
Justice department moves to drop criminal case against Michael Flynn
The department’s decision is a reversal of one of the key cases brought by Robert Mueller in his Trump-Russia investigation
QE, MMT, And Inflation/Deflation
An overview of how QE works and whether that money makes it to the public or not, and under what conditions. A look at the underlying deflationary trends that a
IMAC (NASDAQ:IMAC) & Hanger (NASDAQ:HNGR) Financial Contrast
IMAC (NASDAQ:IMAC) and Hanger (OTCMKTS:HNGR) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, risk, institutional ownership, dividends, profitability, valuation and analyst recommendations. Insider and...
IMAC (NASDAQ:IMAC) versus Hanger (NASDAQ:HNGR) Head-To-Head Analysis
Hanger (OTCMKTS:HNGR) and IMAC (NASDAQ:IMAC) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, profitability, institutional ownership, dividends, earnings, analyst recommendations and valuation. Institutional and...
Apple’s New iMac Leak Reveals Price Cut Plan
With Apple well on its way to refreshing the MacBook line-up, attention turns to the desktop, with a new iMac design sporting a larger screen and plans for a lower price.
Apple’s New iMac Plans Reveal More Price Cuts
With Apple well on its way to refreshing the MacBook line-up, attention turns to the desktop, with a new iMac sporting a larger screen and a lower price.
'Hit by a hurricane': 22m out of work in US as coronavirus takes heavy economic toll
Labor department announces 5.24m people made claims last week, as stay-at-home orders and lockdowns prompt unprecedented wave of layoffs
Imac Holdings (IMAC) Receives a New Rating from Ascendiant
Imac Holdings (IMAC) received a Buy rating from Ascendiant analyst Edward Woo today. The company's shares closed last Tuesday at $1.73. According to
Source: https://incomestatements.info
Category: Stock Reports